Contrasting KORU Medical Systems (KRMD) & The Competition

KORU Medical Systems (NASDAQ:KRMD) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its peers? We will compare KORU Medical Systems to similar businesses based on the strength of its institutional ownership, profitability, analyst recommendations, valuation, dividends, earnings and risk.

Analyst Ratings

This is a summary of recent ratings and price targets for KORU Medical Systems and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1	1	4	0	2.50
KORU Medical Systems Competitors	4274	10549	18323	829	2.46

KORU Medical Systems presently has a consensus target price of $7.00, indicating a potential upside of 126.54%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.30%. Given KORU Medical Systems’ stronger consensus rating and higher possible upside, equities analysts plainly believe KORU Medical Systems is more favorable than its peers.

Profitability

This table compares KORU Medical Systems and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-4.03%	-10.63%	-6.51%
KORU Medical Systems Competitors	-278.24%	-150.08%	-21.87%

Institutional and Insider Ownership

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by company insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Valuation & Earnings

This table compares KORU Medical Systems and its peers top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
KORU Medical Systems	$41.13 million	-$2.64 million	-77.25
KORU Medical Systems Competitors	$1.88 billion	$139.14 million	9.47

KORU Medical Systems’ peers have higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Volatility & Risk

KORU Medical Systems has a beta of 0.47, indicating that its share price is 53% less volatile than the S&P 500. Comparatively, KORU Medical Systems’ peers have a beta of 2.51, indicating that their average share price is 151% more volatile than the S&P 500.

Summary

KORU Medical Systems beats its peers on 8 of the 13 factors compared.

About KORU Medical Systems

KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.